EUVIMEDEUVIMED entdecken
Crossref

Drug Repurposing‐Based Brain‐Targeting Self‐Assembly Nanoplatform Using Enhanced Ferroptosis against Glioblastoma

Jiantang Liang, Lei Li, Hailong Tian, Zhihan Wang, Guowen Liu, Xirui Duan, Meiwen Guo, Jiaqi Liu, Wei Zhang, Edouard C Nice, Canhua Huang, Weifeng He und 2 weitere

Small · 2023-11 · 19 (46)

DOI: 10.1002/smll.202303073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 17.07.2023. Verfasst von Jiantang Liang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Hainan Medical University, Haikou, 570100, China. Hauptthemen laut MEDLINE: Glioblastoma, Ferroptosis, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, 1.3.5 project for disciplines of excellence, Hainan Province Science and Technology Special Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM), the most aggressive and lethal form of malignant brain tumor, is a therapeutic challenge due to the drug filtration capabilities of the blood‐brain barrier (BBB). Interestingly, glioblastoma tends to resist apoptosis during chemotherapy, but is susceptible to ferroptosis. Developing therapies that can effectively target glioblastoma by crossing the BBB and evoke ferroptosis are, therefore, crucial for improving treatment outcomes. Herein, a versatile biomimetic nanoplatform, L‐D‐I/NPs, is designed that self‐assembled by loading the antimalarial drug dihydroartemisinin (DHA) and the photosensitizer indocyanine green (ICG) onto lactoferrin (LF). This nanoplatform can selectively target glioblastoma by binding to low‐density lipoprotein receptor‐related protein‐1 (LRP1) and crossing the BBB, thus inducing glioblastoma cell ferroptosis by boosting intracellular reactive oxygen species (ROS) accumulation and iron overload. In addition, L‐D‐I/NPs have demonstrated the ability to effectively suppress the progression of orthotopic glioblastoma and significantly prolong survival in a mouse glioblastoma model. This nanoplatform has facilitated the application of non‐chemotherapeutic drugs in tumor treatment with minimal adverse effects, paving the way for highly efficient ferroptosis‐based therapies for glioblastoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaFerroptosisGliomaBrain NeoplasmsMiceAnimalsDrug RepositioningBlood-Brain BarrierCell Line, Tumor

Stichwörter der Autor:innen

blood-brain barrierschemophototherapydrug repurposingferroptosisglioblastoma multiforme

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of Hainan Medical University, Haikou, 570100, China.
  • Key Laboratory of Brain Science Research and Transformation in Tropical Environment of Hainan Province, Hainan Medical University, Haikou, 570100, China.
  • Department of Anorectal Surgery, Hospital of Chengdu University of Traditional Chinese Medicine and Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, China.
  • State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, C…
  • Department of Oncology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, China.
  • Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, 3800, Australia.

ORCID-Profile: Qifu Li

Förderung

  • National Natural Science Foundation of China
  • 1.3.5 project for disciplines of excellence
  • Hainan Province Science and Technology Special Fund
  • Hainan Province Clinical Medical Center (2021)
  • Epilepsy Research Science Innovation Group of Hainan Medical University (2022)
  • The Excellent Talent Team of Hainan Province

Zitieren

APA

Liang, J., Li, L., Tian, H., Wang, Z., Liu, G., Duan, X., Guo, M., Liu, J., Zhang, W., Nice, E. C., Huang, C., He, W., Zhang, H., & Li, Q. (2023). Drug Repurposing‐Based Brain‐Targeting Self‐Assembly Nanoplatform Using Enhanced Ferroptosis against Glioblastoma. Small, 19(46). https://doi.org/10.1002/smll.202303073

Vancouver

Liang J, Li L, Tian H, Wang Z, Liu G, Duan X, et al. Drug Repurposing‐Based Brain‐Targeting Self‐Assembly Nanoplatform Using Enhanced Ferroptosis against Glioblastoma. Small. 2023;19(46). doi:10.1002/smll.202303073

BibTeX
@article{Liang2023,
  author = {Liang, Jiantang and Li, Lei and Tian, Hailong and Wang, Zhihan and Liu, Guowen and Duan, Xirui and Guo, Meiwen and Liu, Jiaqi and Zhang, Wei and Nice, Edouard C and Huang, Canhua and He, Weifeng and Zhang, Haiyuan and Li, Qifu},
  title = {Drug Repurposing‐Based Brain‐Targeting Self‐Assembly Nanoplatform Using Enhanced Ferroptosis against Glioblastoma},
  journal = {Small},
  year = {2023},
  volume = {19},
  number = {46},
  doi = {10.1002/smll.202303073}
}
Kostenlos starten →